Skip to main content
STEM $6.34 +1.60%
STEM logo

STEM · Stem, Inc.

Track STEM — free
$6.34 +0.10 (+1.60%) At close · Aug 14
Market Cap
$48.82M
Shares
9.63M
All earnings calls

Earnings call · FY2025 Q3

Stem, Inc. Q3 FY2025 Earnings Call

Stem, Inc. Q3 FY2025 Earnings Call

Concluded Oct 29, 2025
Oct 29, 2025 25 turns
Period
FY2025 Q3
Runtime
Sources
4 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Financial performance / profitability 68 PowerTrack product suite and PowerTrack EMS launch 50 Guidance refinement and outlook 46 Demand environment and macro headwinds 26 Managed services and professional services 16 Strategic transformation / software-centric model 16

Management tone

Positive

Net tone +35 · moderate hedging

Grounding quotes
  • “Our software-centric strategy is delivering results.”
  • “We have reduced the historical volatility in our business. We have derisked the low end of nearly all guidance ranges, and we feel confident about the stability of our business.”
  • “we've already booked significant capacity deployments with blue-chip customers in three different countries, validating both our product capabilities and marketing positioning”
  • “Today, we reported third quarter revenue of $38 million, up 31% year-over-year, with ARR growing 17% year-over-year to $60 million. We achieved our second consecutive quarter of positive adjusted EBITDA and generated positive operating cash flow.”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $38.24M +30.5% YoY
Diluted EPS -$2.84
Gross margin 35.5% +14.3 pp YoY
Net income -$23.79M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

United States$36.07M +31.5% YoY
Non Us$2.17M +16.3% YoY
Full-screen source Call document